Home » Biotechnology » Molecular Diagnostics Market

Molecular Diagnostics Market By Product (Instruments, Reagents, Others); By Application (Pharmacogenomics, Neurological Disease, Cardiovascular Disease, Microbiology); By Test Location (Point of Care, Self-Test or OTC, Central Laboratories); By Technology (In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology [INAAT], Chips and Microarrays, Mass Spectrometry, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Name: Molecular Diagnostics Market - Demand, Size and Competitive Analysis
Creator: Credence Research Inc.
Published: 2024-11-09
License: https://www.credenceresearch.com/info/privacy-policy
Keywords: Molecular Diagnostics Market

Summary
Table Of Content
Request Sample

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Molecular Diagnostics Market Size 2023	USD 15,293.47 million
Molecular Diagnostics Market, CAGR	4.75%
Molecular Diagnostics MarketSize 2032	USD 23,221.61 million

Market Overview

The Molecular Diagnostics Market is projected to grow from USD 15,293.47 million in 2023 to an estimated USD 23,221.61 million by 2032, with a compound annual growth rate (CAGR) of 4.75% from 2024 to 2032. This robust expansion is driven by the increasing adoption of personalized medicine, rising prevalence of infectious diseases, and a growing need for rapid and accurate diagnostic testing.

Key market drivers include technological advancements in molecular diagnostics, such as the development of next-generation sequencing (NGS) and point-of-care molecular testing, which enhance diagnostic accuracy and reduce turnaround times. Moreover, increasing demand for biomarkers and companion diagnostics to support targeted therapies is fueling market growth. Favorable government policies and significant investments in healthcare infrastructure further support market expansion, while trends toward decentralized testing continue to shape the industry landscape.

Geographically, North America dominates the molecular diagnostics market, attributed to well-established healthcare systems, high adoption rates of advanced diagnostics, and ongoing R&D initiatives. Europe follows, benefiting from supportive healthcare policies and robust laboratory networks. The Asia-Pacific region is expected to witness the fastest growth due to rising healthcare spending and increasing awareness of early disease diagnosis. Key market players include Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Hologic Inc., and Qiagen, who lead the market through innovative product offerings and strategic collaborations.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

Market Drivers

Rising Prevalence of Infectious Diseases and Chronic Conditions

The increasing prevalence of infectious diseases, such as COVID-19, HIV, and tuberculosis, as well as chronic conditions, including cancer and genetic disorders, significantly drives the molecular diagnostics market. The necessity for rapid and accurate testing solutions has heightened in light of recent global pandemics and the growing burden of chronic diseases worldwide. Molecular diagnostics offer highly sensitive and specific tools to detect pathogens, mutations, and genetic markers, leading to earlier diagnosis and more effective patient management. This capability has been further underscored during the COVID-19 pandemic, where molecular diagnostic tests, particularly polymerase chain reaction (PCR)-based assays, became critical in disease detection and outbreak control. Furthermore, the ongoing need for monitoring and managing chronic conditions has spurred the adoption of molecular tests to guide therapeutic decision-making, enabling better patient outcomes. For instance, in the U.S. alone, there were 3.8 million emergency department visits related to infectious and parasitic diseases in 2021, highlighting the significant burden these diseases place on healthcare systems. Additionally, chronic conditions such as diabetes affected nearly 31.9 million adults in 2023, further emphasizing the growing need for advanced diagnostic solutions.

Technological Advancements and Innovation in Diagnostic Tools

Continuous innovation in molecular diagnostics technologies is a pivotal driver for market growth. The development of next-generation sequencing (NGS), digital PCR, microarray technologies, and other advanced testing modalities has transformed molecular diagnostics, allowing for higher precision, faster turnaround times, and more comprehensive disease profiling. NGS, for instance, facilitates large-scale genomic analysis, enabling precise identification of genetic mutations and biomarkers associated with various diseases, including cancer. Similarly, point-of-care molecular diagnostics have emerged to meet the demand for quick and actionable results outside of traditional laboratory settings, providing timely and efficient testing in decentralized locations. These technological advancements have made molecular diagnostics more accessible, reducing costs, improving patient outcomes, and expanding the market’s reach across diverse healthcare environments.For instance, next-generation sequencing (NGS) has revolutionized genomic analysis by enabling large-scale identification of genetic mutations. This technology is crucial in cancer diagnostics, where it helps identify specific mutations that guide targeted therapies. In fact, comprehensive genomic profiling tests like FoundationOne CDx have been approved for multiple cancer treatments, offering critical insights into personalized care.

Growing Focus on Personalized Medicine and Companion Diagnostics

The rising emphasis on personalized medicine is another significant driver boosting the molecular diagnostics market. Personalized medicine aims to tailor treatments based on individual patient profiles, including genetic, molecular, and environmental factors. This approach relies heavily on molecular diagnostic tools to identify biomarkers that guide targeted therapies, optimize drug efficacy, and minimize adverse effects. The increasing availability and demand for companion diagnostics—tests that help predict patient response to specific therapies—are contributing to the market’s expansion. Companion diagnostics are widely used in oncology, where they assist in selecting the most appropriate treatment based on the genetic makeup of a tumor. For pharmaceutical companies, the integration of companion diagnostics with novel therapeutics enhances clinical success rates and improves patient outcomes, driving further investment and innovation in the field.For instance, in 2023, personalized medicines accounted for over one-third of new drug approvals by the U.S. FDA, with 26 new personalized treatments introduced—including seven for cancer and several others for rare diseases. This growing trend underscores the importance of companion diagnostics in guiding targeted therapies based on individual genetic profiles.

Increasing Government Support and Investments in Healthcare Infrastructure

Supportive government policies, increased public and private investments, and improved healthcare infrastructure are vital drivers propelling the molecular diagnostics market. Many countries have implemented initiatives and funding programs aimed at promoting the development and deployment of advanced diagnostic technologies. For example, government-backed projects focusing on infectious disease testing, cancer screening, and genetic testing have provided financial incentives for research and development. Regulatory authorities, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have also introduced streamlined approval pathways for innovative molecular tests, fostering market growth. Furthermore, the expansion of healthcare infrastructure in emerging markets, particularly in Asia-Pacific and Latin America, has accelerated access to molecular diagnostics. This development ensures better reach and improved healthcare outcomes for a larger segment of the population, creating a positive impact on market growth. Additionally, collaborations between public and private sectors have fueled technological advancements and facilitated widespread adoption, enhancing the global market presence of molecular diagnostics solutions.

Market Trends

Growing Demand for Point-of-Care (POC) Molecular Diagnostics

The molecular diagnostics market is witnessing a strong shift toward point-of-care (POC) testing solutions. This trend is driven by the increasing need for rapid, accurate, and actionable diagnostic results, particularly in emergency and remote settings. POC molecular diagnostics allow healthcare professionals to conduct tests closer to patients, significantly reducing the turnaround time and expediting clinical decision-making. The rise of portable and easy-to-use molecular testing devices has enhanced accessibility to diagnostic tools, leading to improved patient outcomes in various care settings, such as clinics, community health centers, and even at-home testing kits. The COVID-19 pandemic further accelerated the adoption of POC molecular diagnostics, with demand surging for quick and reliable testing to control and monitor the spread of the virus. For instance, during the COVID-19 pandemic, point-of-care (POC) molecular diagnostics played a crucial role in managing the spread of the virus. Rapid POC molecular tests allowed healthcare providers to quickly identify infected individuals, even in remote or emergency settings, significantly reducing the time between testing and clinical decision-making. This rapid response was essential for controlling outbreaks and ensuring timely treatment in critical care scenarios.

Integration of Artificial Intelligence (AI) and Data Analytics

The integration of artificial intelligence (AI) and advanced data analytics is reshaping the molecular diagnostics landscape, enhancing accuracy, efficiency, and scalability of diagnostic solutions. AI algorithms are being leveraged to analyze complex genetic and molecular data, enabling the identification of disease patterns, biomarkers, and potential treatment targets with unprecedented precision. AI-driven tools are capable of processing vast datasets rapidly, which aids in faster diagnosis, predictive analytics, and personalized treatment recommendations. In addition, AI is improving automation in molecular diagnostics workflows, reducing human errors and boosting laboratory productivity. Advanced data analytics platforms also facilitate real-time tracking of infectious disease outbreaks and epidemiological trends, providing actionable insights for public health responses.This integration of AI and data-driven analytics is transforming how clinicians, researchers, and public health agencies utilize molecular diagnostics to optimize healthcare delivery, contributing to ongoing advancements and growth in the market.

Market Restraints and Challenges

High Costs and Limited Accessibility

One of the primary restraints in the molecular diagnostics market is the high cost associated with advanced testing technologies and procedures. The development, production, and implementation of molecular diagnostic tests, such as next-generation sequencing (NGS) and digital PCR, often entail substantial expenses, making them less accessible to healthcare providers in low-resource settings. Additionally, specialized equipment, reagents, and skilled personnel are required to operate these complex diagnostic platforms, further driving up costs and limiting widespread adoption. In many regions, particularly low- and middle-income countries, healthcare systems struggle to integrate and scale molecular diagnostics due to financial constraints and infrastructure gaps. This cost barrier can hinder patient access to timely and accurate diagnostic tests, posing a challenge to equitable healthcare delivery. While efforts are being made to reduce costs and broaden accessibility through innovations and subsidies, affordability remains a significant challenge in scaling these technologies across diverse populations.

Regulatory Complexities and Approval Delays

Stringent regulatory requirements and complex approval processes present another significant challenge for the molecular diagnostics market. Due to the critical role of molecular diagnostic tests in patient care, regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), enforce rigorous validation protocols and compliance standards. While these measures are essential for ensuring safety and accuracy, they can also create prolonged delays in product approvals and market entry. The evolving regulatory landscape for new and emerging technologies, such as companion diagnostics and liquid biopsies, can lead to inconsistencies and slow the commercialization of innovative solutions. For manufacturers, navigating the regulatory environment often involves significant time and resource investments, which can impede innovation and increase costs. Harmonizing international regulatory standards and streamlining approval pathways will be crucial in addressing these challenges and accelerating market growth.

Market Segmentation Analysis

By Product

The molecular diagnostics market is segmented by product into three main categories. The instruments segment comprises advanced diagnostic equipment, including PCR machines, sequencers, and other molecular diagnostic tools, which are essential for performing complex tests and represent a significant revenue source. The reagents segment includes critical components such as chemicals, enzymes, and kits necessary for conducting molecular tests, with steady growth anticipated due to the continuous demand for testing. Additionally, the others category covers consumables and ancillary products like software and data analysis tools, which are becoming increasingly vital for enhancing laboratory operations and efficiency.

By application

The molecular diagnostics market is segmented by application into several key areas. Pharmacogenomics focuses on how genetic variations influence individual responses to medications, driving growth as personalized medicine gains traction. In the realm of neurological diseases, molecular diagnostics are essential for diagnosing disorders like Alzheimer’s and Parkinson’s through genetic testing and biomarker identification. The cardiovascular segment is also witnessing increased demand for early detection of heart diseases and genetic risk assessments. Additionally, microbiology plays a critical role in detecting infectious agents, including bacteria, viruses, and fungi, with rapid testing becoming crucial following recent pandemics. Finally, the market also encompasses oncology and genetic testing for inherited disorders, which are increasingly recognized as awareness around these conditions grows.

Segments

Based on Product

Instruments
Reagents
Others

Based on Application

Pharmacogenomics
Neurological Disease
Cardiovascular Disease
Microbiology

Based on Test Location

Point of Care
Self-Test or OTC
Central Laboratories

Based on Technology

In Situ Hybridization
Isothermal Nucleic Acid Amplification Technology (INAAT)
Chips and Microarrays
Mass Spectrometry
Others

Based on Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

Regional Analysis

North America (40%)

North America leads the molecular diagnostics market, accounting for approximately 40% of the global share. This dominance is primarily attributed to advanced healthcare infrastructure, high levels of investment in research and development, and a strong presence of major market players. The United States, in particular, has been at the forefront of adopting innovative molecular diagnostic technologies, driven by increasing prevalence rates of chronic diseases and a growing focus on personalized medicine. Additionally, favorable reimbursement policies and a well-established regulatory framework further enhance the region’s market position.

Europe (30%)

Europe holds around 30% of the molecular diagnostics market share, benefiting from a robust healthcare system and supportive government initiatives aimed at improving healthcare delivery. Countries such as Germany, the UK, and France are significant contributors to this market, with strong emphasis on research and innovation in diagnostics. The European region is also witnessing increasing collaboration between public and private sectors to enhance molecular diagnostic capabilities. Furthermore, the growing prevalence of infectious diseases and the rising demand for personalized medicine are key drivers of market growth in this region.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key players

BD
bio Merieux SA
Bio-Rad Laboratories, Inc.
Abbott
Agilent Technologies, Inc.
Danaher
Hologic Inc. (Gen Probe)
Illumina, Inc.
Grifols, S.A.
QIAGEN
Hoffmann-La Roche, Ltd.
Siemens Healthineers AG
Sysmex Corporation

Competitive Analysis

The molecular diagnostics market is characterized by strong competition among key players, each leveraging unique strengths to capture market share. Companies such as Roche and Abbott excel in their extensive product portfolios, offering a range of advanced diagnostic solutions that address various medical needs. Innovators like Illumina and Thermo Fisher Scientific lead in technological advancements, focusing on next-generation sequencing and precision diagnostics. Additionally, firms such as Hologic and QIAGEN emphasize strategic partnerships and collaborations to enhance their market position. The landscape is further shaped by ongoing mergers and acquisitions, enabling companies to expand their capabilities and reach. As personalized medicine and rapid diagnostic solutions gain prominence, these key players are well-positioned to adapt and thrive, driving continued growth in the molecular diagnostics market.

Recent Developments

In February 2024, BioMérieux received FDA clearance and a CLIA waiver for its SpotFire molecular diagnostics system, aimed at point-of-care testing. This system is expected to drive future growth in BioMérieux’s molecular biology business.

In July 2024, Danaher launched two new CLIA- and CAP-certified diagnostic labs to accelerate the development of companion diagnostics (CDx) and complementary diagnostics (CoDx).

In July 2024, Illumina acquired Fluent BioSciences to expand its single-cell analysis technology and enhance its multiomics capabilities.

In May 2024, Grifols announced a €130 million investment to expand its Barcelona industrial complex with new purification and fill-and-finish facilities for its Bioscience Division and a new R&D center.

In 2024, QIAGEN announced plans for the U.S. regulatory submission of a new syndromic panel for meningitis as part of its QIAstat-Dx product line.

In July 2024, Siemens Healthineers acquired Novartis’ radiopharmaceutical business for €200 million ($223 million), expanding its PET imaging capabilities across Europe.

Market Concentration and Characteristics

The molecular diagnostics market exhibits moderate concentration, characterized by a diverse range of players, from established multinational corporations to emerging companies. Major players such as Roche, Abbott, and Thermo Fisher dominate the market, leveraging extensive research and development capabilities, broad product portfolios, and strong distribution networks to maintain competitive advantages. The market is characterized by rapid technological advancements, particularly in areas such as next-generation sequencing and point-of-care testing, which drive innovation and create opportunities for new entrants. Additionally, the increasing demand for personalized medicine and companion diagnostics is fostering collaboration among key stakeholders, including pharmaceutical companies and diagnostic manufacturers, further intensifying competition. As healthcare systems globally prioritize early disease detection and patient-centered care, the molecular diagnostics market continues to evolve, marked by strategic partnerships, mergers, and acquisitions aimed at enhancing product offerings and expanding market reach.

Report Coverage

The research report offers an in-depth analysis based on Product, Application, Test Location, Technology and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The demand for personalized medicine will continue to rise, driving advancements in molecular diagnostics that cater to individual patient profiles and genetic variations.

Ongoing innovations in testing technologies, such as next-generation sequencing (NGS) and digital PCR, will enhance the sensitivity and specificity of molecular diagnostic tests.

The trend towards point-of-care testing will gain momentum, enabling faster diagnostic results in various healthcare settings, particularly in remote and underserved areas.

With a heightened focus on public health due to recent pandemics, the market for infectious disease molecular diagnostics is expected to expand significantly, emphasizing rapid testing solutions.

The incorporation of artificial intelligence and machine learning into molecular diagnostics will streamline data analysis, improve diagnostic accuracy, and facilitate personalized treatment plans.

As the market evolves, regulatory frameworks will adapt to accommodate new technologies, potentially streamlining approval processes and encouraging innovation in molecular diagnostics.

The increasing preference for less invasive diagnostic methods, such as liquid biopsies, will drive growth in cancer diagnostics, allowing for earlier detection and better monitoring of treatment responses.

Emerging markets in Asia-Pacific, Latin America, and Africa will experience significant growth in molecular diagnostics as healthcare infrastructure improves and access to advanced diagnostic tools increases.

The collaboration between pharmaceutical companies and diagnostic developers will intensify, promoting the use of companion diagnostics to enhance targeted therapies and improve patient outcomes.

As the molecular diagnostics market continues to expand, there will be increased investment in research and development, fostering innovation and the introduction of next-generation diagnostic solutions that address unmet clinical needs.

CHAPTER NO. 1 : INTRODUCTION 30

1.1.1. Report Description 30
Purpose of the Report 30
USP & Key Offerings 30
1.1.2. Key Benefits for Stakeholders 30
1.1.3. Target Audience 31
1.1.4. Report Scope 31
1.1.5. Regional Scope 32
CHAPTER NO. 2 : EXECUTIVE SUMMARY 33
2.1. Molecular Diagnostics Market Snapshot 33
2.1.1. Global Molecular Diagnostics Market, 2018 – 2032 (USD Million) 35
CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 36
3.1. Russia-Ukraine and Israel-Palestine War Impacts 36
CHAPTER NO. 4 : MOLECULAR DIAGNOSTICS MARKET – INDUSTRY ANALYSIS 37
4.1. Introduction 37
4.2. Market Drivers 38
4.2.1. Driving Factor 1 Analysis 38
4.2.2. Driving Factor 2 Analysis 39
4.3. Market Restraints 40
4.3.1. Restraining Factor Analysis 40
4.4. Market Opportunities 41
4.4.1. Market Opportunity Analysis 41
4.5. Porter’s Five Forces Analysis 42
CHAPTER NO. 5 : ANALYSIS COMPETITIVE LANDSCAPE 43
5.1. Company Market Share Analysis – 2023 43
5.1.1. Global Molecular Diagnostics Market: Company Market Share, by Volume, 2023 43
5.1.2. Global Molecular Diagnostics Market: Company Market Share, by Revenue, 2023 44
5.1.3. Global Molecular Diagnostics Market: Top 6 Company Market Share, by Revenue, 2023 44
5.1.4. Global Molecular Diagnostics Market: Top 3 Company Market Share, by Revenue, 2023 45
5.2. Global Molecular Diagnostics Market Company Revenue Market Share, 2023 46
5.3. Company Assessment Metrics, 2023 47
5.3.1. Stars 47
5.3.2. Emerging Leaders 47
5.3.3. Pervasive Players 47
5.3.4. Participants 47
5.4. Start-ups /SMEs Assessment Metrics, 2023 47
5.4.1. Progressive Companies 47
5.4.2. Responsive Companies 47
5.4.3. Dynamic Companies 47
5.4.4. Starting Blocks 47
5.5. Strategic Developments 48
5.5.1. Acquisitions & Mergers 48
New Product Launch 48
Regional Expansion 48
5.6. Key Players Product Matrix 49
CHAPTER NO. 6 : PESTEL & ADJACENT MARKET ANALYSIS 50
6.1. PESTEL 50
6.1.1. Political Factors 50
6.1.2. Economic Factors 50
6.1.3. Social Factors 50
6.1.4. Technological Factors 50
6.1.5. Environmental Factors 50
6.1.6. Legal Factors 50
6.2. Adjacent Market Analysis 50
CHAPTER NO. 7 : MOLECULAR DIAGNOSTICS MARKET – BY PRODUCT SEGMENT ANALYSIS 51
7.1. Molecular Diagnostics Market Overview, by Product Segment 51
7.1.1. Molecular Diagnostics Market Revenue Share, By Product, 2023 & 2032 52
7.1.2. Molecular Diagnostics Market Attractiveness Analysis, By Product 53
7.1.3. Incremental Revenue Growth Opportunity, by Product, 2024 – 2032 53
7.1.4. Molecular Diagnostics Market Revenue, By Product, 2018, 2023, 2027 & 2032 54
7.2. Instruments 55
7.2.1. Global Instruments Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 56
7.2.2. Global Instruments Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 56
7.3. Reagents 57
7.3.1. Global Reagents Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 58
7.3.2. Global Reagents Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 58
7.4. Others 59
7.4.1. Global Others Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 60
7.4.2. Global Others Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 60
CHAPTER NO. 8 : MOLECULAR DIAGNOSTICS MARKET – BY APPLICATION SEGMENT ANALYSIS 61
8.1. Molecular Diagnostics Market Overview, by Application Segment 61
8.1.1. Molecular Diagnostics Market Revenue Share, By Application, 2023 & 2032 62
8.1.2. Molecular Diagnostics Market Attractiveness Analysis, By Application 63
8.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 63
8.1.4. Molecular Diagnostics Market Revenue, By Application, 2018, 2023, 2027 & 2032 64
8.2. Pharmacogenomics 65
8.2.1. Global Pharmacogenomics Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 66
8.2.2. Global Pharmacogenomics Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 66
8.3. Neurological Disease 67
8.3.1. Global Neurological Disease Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 68
8.3.2. Global Neurological Disease Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 68
8.4. Cardiovascular Disease 69
8.4.1. Global Cardiovascular Disease Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 70
8.4.2. Global Cardiovascular Disease Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 70
8.5. Microbiology 71
8.5.1. Global Microbiology Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 72
8.5.2. Global Microbiology Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 72
8.6. Others 73
8.6.1. Global Others Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 74
8.6.2. Global Others Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 74
CHAPTER NO. 9 : MOLECULAR DIAGNOSTICS MARKET – BY TEST LOCATION SEGMENT ANALYSIS 75
9.1. Molecular Diagnostics Market Overview, by Test Location Segment 75
9.1.1. Molecular Diagnostics Market Revenue Share, By Test Location, 2023 & 2032 76
9.1.2. Molecular Diagnostics Market Attractiveness Analysis, By Test Location 77
9.1.3. Incremental Revenue Growth Opportunity, by Test Location, 2024 – 2032 77
9.1.4. Molecular Diagnostics Market Revenue, By Test Location, 2018, 2023, 2027 & 2032 78
9.2. Point of Care 79
9.2.1. Global Point of Care Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 80
9.2.2. Global Point of Care Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 80
9.3. Self-test or OTC 81
9.3.1. Global Self-test or OTC Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 82
9.3.2. Global Self-test or OTC Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 82
9.4. Central Laboratories 83
9.4.1. Global Central Laboratories Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 84
9.4.2. Global Central Laboratories Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 84
CHAPTER NO. 10 : MOLECULAR DIAGNOSTICS MARKET – BY TECHNOLOGY SEGMENT ANALYSIS 85
10.1. Molecular Diagnostics Market Overview, by Technology Segment 85
10.1.1. Molecular Diagnostics Market Revenue Share, By Technology, 2023 & 2032 86
10.1.2. Molecular Diagnostics Market Attractiveness Analysis, By Technology 87
10.1.3. Incremental Revenue Growth Opportunity, by Technology, 2024 – 2032 87
10.1.4. Molecular Diagnostics Market Revenue, By Technology, 2018, 2023, 2027 & 2032 88
10.2. In Situ Hybridization 89
10.2.1. Global In Situ Hybridization Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 90
10.2.2. Global In Situ Hybridization Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 90
10.3. Isothermal Nucleic Acid Amplification Technology 91
10.3.1. Global Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 92
10.3.2. Global Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 92
10.4. Chips and Microarrays 93
10.4.1. Global Chips and Microarrays Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 94
10.4.2. Global Chips and Microarrays Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 94
10.5. Mass Spectrometry 95
10.5.1. Global Mass Spectrometry Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 96
10.5.2. Global Mass Spectrometry Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 96
10.6. Others 97
10.6.1. Global Others Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 98
10.6.2. Global Others Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 98
CHAPTER NO. 11 : MOLECULAR DIAGNOSTICS MARKET – REGIONAL ANALYSIS 99
11.1. Molecular Diagnostics Market Overview, by Regional Segments 99
11.2. Region 100
11.2.1. Global Molecular Diagnostics Market Revenue Share, By Region, 2023 & 2032 100
11.2.2. Molecular Diagnostics Market Attractiveness Analysis, By Region 101
11.2.3. Incremental Revenue Growth Opportunity, by Region, 2024 – 2032 101
11.2.4. Molecular Diagnostics Market Revenue, By Region, 2018, 2023, 2027 & 2032 102
11.2.5. Global Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 103
11.2.6. Global Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 103
11.3. Product 104
11.3.1. Global Molecular Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 104
11.4. Global Molecular Diagnostics Market Revenue, By Product, 2024 – 2032 (USD Million) 104
11.5. Application 105
11.5.1. Global Molecular Diagnostics Market Revenue, By Application, 2018 – 2023 (USD Million) 105
11.5.2. Global Molecular Diagnostics Market Revenue, By Application, 2024 – 2032 (USD Million) 105
11.6. Test Location 106
11.6.1. Global Molecular Diagnostics Market Revenue, By Test Location, 2018 – 2023 (USD Million) 106
11.6.2. Global Molecular Diagnostics Market Revenue, By Test Location, 2024 – 2032 (USD Million) 106
11.7. Technology 107
11.7.1. Global Molecular Diagnostics Market Revenue, By Technology, 2018 – 2023 (USD Million) 107
11.7.2. Global Molecular Diagnostics Market Revenue, By Technology, 2024 – 2032 (USD Million) 107
CHAPTER NO. 12 : MOLECULAR DIAGNOSTICS MARKET – NORTH AMERICA 108
12.1. North America 108
12.1.1. Key Highlights 108
12.1.2. North America Molecular Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 109
12.1.3. North America Molecular Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 110
12.1.4. North America Molecular Diagnostics Market Revenue, By Application, 2018 – 2023 (USD Million) 111
12.1.5. North America Molecular Diagnostics Market Revenue, By Test Location, 2018 – 2023 (USD Million) 112
12.1.6. North America Molecular Diagnostics Market Revenue, By Technology, 2018 – 2023 (USD Million) 113
12.2. U.S. 114
12.3. Canada 114
12.4. Mexico 114
CHAPTER NO. 13 : MOLECULAR DIAGNOSTICS MARKET – EUROPE 115
13.1. Europe 115
13.1.1. Key Highlights 115
13.1.2. Europe Molecular Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 116
13.1.3. Europe Molecular Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 117
13.1.4. Europe Molecular Diagnostics Market Revenue, By Application, 2018 – 2023 (USD Million) 118
13.1.5. Europe Molecular Diagnostics Market Revenue, By Test Location, 2018 – 2023 (USD Million) 119
13.1.6. Europe Molecular Diagnostics Market Revenue, By Technology, 2018 – 2023 (USD Million) 120
13.2. UK 121
13.3. France 121
13.4. Germany 121
13.5. Italy 121
13.6. Spain 121
13.7. Russia 121
13.8. Belgium 121
13.9. Netherland 121
13.10. Austria 121
13.11. Sweden 121
13.12. Poland 121
13.13. Denmark 121
13.14. Switzerland 121
13.15. Rest of Europe 121
CHAPTER NO. 14 : MOLECULAR DIAGNOSTICS MARKET – ASIA PACIFIC 122
14.1. Asia Pacific 122
14.1.1. Key Highlights 122
14.1.2. Asia Pacific Molecular Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 123
14.1.3. Asia Pacific Molecular Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 124
14.1.4. Asia Pacific Molecular Diagnostics Market Revenue, By Application, 2018 – 2023 (USD Million) 125
14.1.5. Asia Pacific Molecular Diagnostics Market Revenue, By Test Location, 2018 – 2023 (USD Million) 126
14.1.6. Asia Pacific Molecular Diagnostics Market Revenue, By Technology, 2018 – 2023 (USD Million) 127
14.2. China 128
14.3. Japan 128
14.4. South Korea 128
14.5. India 128
14.6. Australia 128
14.7. Thailand 128
14.8. Indonesia 128
14.9. Vietnam 128
14.10. Malaysia 128
14.11. Philippines 128
14.12. Taiwan 128
14.13. Rest of Asia Pacific 128
CHAPTER NO. 15 : MOLECULAR DIAGNOSTICS MARKET – LATIN AMERICA 129
15.1. Latin America 129
15.1.1. Key Highlights 129
15.1.2. Latin America Molecular Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 130
15.1.3. Latin America Molecular Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 131
15.1.4. Latin America Molecular Diagnostics Market Revenue, By Application, 2018 – 2023 (USD Million) 132
15.1.5. Latin America Molecular Diagnostics Market Revenue, By Test Location, 2018 – 2023 (USD Million) 133
15.1.6. Latin America Molecular Diagnostics Market Revenue, By Technology, 2018 – 2023 (USD Million) 134
15.2. Brazil 135
15.3. Argentina 135
15.4. Peru 135
15.5. Chile 135
15.6. Colombia 135
15.7. Rest of Latin America 135
CHAPTER NO. 16 : MOLECULAR DIAGNOSTICS MARKET – MIDDLE EAST 136
16.1. Middle East 136
16.1.1. Key Highlights 136
16.1.2. Middle East Molecular Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 137
16.1.3. Middle East Molecular Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 138
16.1.4. Middle East Molecular Diagnostics Market Revenue, By Application, 2018 – 2023 (USD Million) 139
16.1.5. Middle East Molecular Diagnostics Market Revenue, By Test Location, 2018 – 2023 (USD Million) 140
16.1.6. Middle East Molecular Diagnostics Market Revenue, By Technology, 2018 – 2023 (USD Million) 141
16.2. UAE 142
16.3. KSA 142
16.4. Israel 142
16.5. Turkey 142
16.6. Iran 142
16.7. Rest of Middle East 142
CHAPTER NO. 17 : MOLECULAR DIAGNOSTICS MARKET – AFRICA 143
17.1. Africa 143
17.1.1. Key Highlights 143
17.1.2. Africa Molecular Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 144
17.1.3. Africa Molecular Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 145
17.1.4. Africa Molecular Diagnostics Market Revenue, By Application, 2018 – 2023 (USD Million) 146
17.1.5. Africa Molecular Diagnostics Market Revenue, By Test Location, 2018 – 2023 (USD Million) 147
17.1.6. Africa Molecular Diagnostics Market Revenue, By Technology, 2018 – 2023 (USD Million) 148
17.2. Egypt 149
17.3. Nigeria 149
17.4. Algeria 149
17.5. Morocco 149
17.6. Rest of Africa 149
CHAPTER NO. 18 : COMPANY PROFILES 150
18.1. BD 150
18.1.1. Company Overview 150
18.1.2. Product Portfolio 150
18.1.3. Swot Analysis 150
18.1.4. Business Strategy 151
18.1.5. Financial Overview 151
18.2. bio Meraux SA 152
18.3. Bio-Rad Laboratories, Inc. 152
18.4. Abbott 152
18.5. Agilent Technologies, Inc. 152
18.6. Danaher 152
18.7. Hologic Inc. (Gen Probe) 152
18.8. Illumina, Inc. 152
18.9. Grifols, S.A. 152
18.10. QIAGEN 152
18.11. F. Hoffmann-La Roche, Ltd. 152
18.12. Siemens Healthiness AG 152
18.13. Sysmex Corporation 152
18.14. Company 14 152

List of Figures
FIG NO. 1. Global Molecular Diagnostics Market Revenue, 2018 – 2032 (USD Million) 34
FIG NO. 2. Porter’s Five Forces Analysis for Global Molecular Diagnostics Market 41
FIG NO. 3. Company Share Analysis, 2023 42
FIG NO. 4. Company Share Analysis, 2023 43
FIG NO. 5. Company Share Analysis, 2023 43
FIG NO. 6. Company Share Analysis, 2023 44
FIG NO. 7. Molecular Diagnostics Market – Company Revenue Market Share, 2023 45
FIG NO. 8. Molecular Diagnostics Market Revenue Share, By Product, 2023 & 2032 51
FIG NO. 9. Market Attractiveness Analysis, By Product 52
FIG NO. 10. Incremental Revenue Growth Opportunity by Product, 2024 – 2032 52
FIG NO. 11. Molecular Diagnostics Market Revenue, By Product, 2018, 2023, 2027 & 2032 53
FIG NO. 12. Global Molecular Diagnostics Market for Instruments, Revenue (USD Million) 2018 – 2032 54
FIG NO. 13. Global Molecular Diagnostics Market for Reagents, Revenue (USD Million) 2018 – 2032 56
FIG NO. 14. Global Molecular Diagnostics Market for Others, Revenue (USD Million) 2018 – 2032 58
FIG NO. 15. Molecular Diagnostics Market Revenue Share, By Application, 2023 & 2032 61
FIG NO. 16. Market Attractiveness Analysis, By Application 62
FIG NO. 17. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 62
FIG NO. 18. Molecular Diagnostics Market Revenue, By Application, 2018, 2023, 2027 & 2032 63
FIG NO. 19. Global Molecular Diagnostics Market for Pharmacogenomics, Revenue (USD Million) 2018 – 2032 64
FIG NO. 20. Global Molecular Diagnostics Market for Neurological Disease, Revenue (USD Million) 2018 – 2032 66
FIG NO. 21. Global Molecular Diagnostics Market for Cardiovascular Disease, Revenue (USD Million) 2018 – 2032 68
FIG NO. 22. Global Molecular Diagnostics Market for Microbiology, Revenue (USD Million) 2018 – 2032 70
FIG NO. 23. Global Molecular Diagnostics Market for Others, Revenue (USD Million) 2018 – 2032 72
FIG NO. 24. Molecular Diagnostics Market Revenue Share, By Test Location, 2023 & 2032 75
FIG NO. 25. Market Attractiveness Analysis, By Test Location 76
FIG NO. 26. Incremental Revenue Growth Opportunity by Test Location, 2024 – 2032 76
FIG NO. 27. Molecular Diagnostics Market Revenue, By Test Location, 2018, 2023, 2027 & 2032 77
FIG NO. 28. Global Molecular Diagnostics Market for Point of Care, Revenue (USD Million) 2018 – 2032 78
FIG NO. 29. Global Molecular Diagnostics Market for Self-test or OTC, Revenue (USD Million) 2018 – 2032 80
FIG NO. 30. Global Molecular Diagnostics Market for Central Laboratories, Revenue (USD Million) 2018 – 2032 82
FIG NO. 31. Molecular Diagnostics Market Revenue Share, By Technology, 2023 & 2032 85
FIG NO. 32. Market Attractiveness Analysis, By Technology 86
FIG NO. 33. Incremental Revenue Growth Opportunity by Technology, 2024 – 2032 86
FIG NO. 34. Molecular Diagnostics Market Revenue, By Technology, 2018, 2023, 2027 & 2032 87
FIG NO. 35. Global Molecular Diagnostics Market for In Situ Hybridization, Revenue (USD Million) 2018 – 2032 88
FIG NO. 36. Global Molecular Diagnostics Market for Isothermal Nucleic Acid Amplification Technology, Revenue (USD Million) 2018 – 2032 90
FIG NO. 37. Global Molecular Diagnostics Market for Chips and Microarrays, Revenue (USD Million) 2018 – 2032 92
FIG NO. 38. Global Molecular Diagnostics Market for Mass Spectrometry, Revenue (USD Million) 2018 – 2032 94
FIG NO. 39. Global Molecular Diagnostics Market for Others, Revenue (USD Million) 2018 – 2032 96
FIG NO. 40. Global Molecular Diagnostics Market Revenue Share, By Region, 2023 & 2032 99
FIG NO. 41. Market Attractiveness Analysis, By Region 100
FIG NO. 42. Incremental Revenue Growth Opportunity by Region, 2024 – 2032 100
FIG NO. 43. Molecular Diagnostics Market Revenue, By Region, 2018, 2023, 2027 & 2032 101
FIG NO. 44. North America Molecular Diagnostics Market Revenue, 2018 – 2032 (USD Million) 107
FIG NO. 45. Europe Molecular Diagnostics Market Revenue, 2018 – 2032 (USD Million) 114
FIG NO. 46. Asia Pacific Molecular Diagnostics Market Revenue, 2018 – 2032 (USD Million) 121
FIG NO. 47. Latin America Molecular Diagnostics Market Revenue, 2018 – 2032 (USD Million) 128
FIG NO. 48. Middle East Molecular Diagnostics Market Revenue, 2018 – 2032 (USD Million) 135
FIG NO. 49. Africa Molecular Diagnostics Market Revenue, 2018 – 2032 (USD Million) 142

List of Tables
TABLE NO. 1. : Global Molecular Diagnostics Market: Snapshot 31
TABLE NO. 2. : Drivers for the Molecular Diagnostics Market: Impact Analysis 36
TABLE NO. 3. : Restraints for the Molecular Diagnostics Market: Impact Analysis 38
TABLE NO. 4. : Global Instruments Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 54
TABLE NO. 5. : Global Instruments Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 54
TABLE NO. 6. : Global Reagents Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 56
TABLE NO. 7. : Global Reagents Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 56
TABLE NO. 8. : Global Others Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 58
TABLE NO. 9. : Global Others Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 58
TABLE NO. 10. : Global Pharmacogenomics Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 64
TABLE NO. 11. : Global Pharmacogenomics Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 64
TABLE NO. 12. : Global Neurological Disease Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 66
TABLE NO. 13. : Global Neurological Disease Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 66
TABLE NO. 14. : Global Cardiovascular Disease Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 68
TABLE NO. 15. : Global Cardiovascular Disease Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 68
TABLE NO. 16. : Global Microbiology Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 70
TABLE NO. 17. : Global Microbiology Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 70
TABLE NO. 18. : Global Others Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 72
TABLE NO. 19. : Global Others Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 72
TABLE NO. 20. : Global Point of Care Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 78
TABLE NO. 21. : Global Point of Care Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 78
TABLE NO. 22. : Global Self-test or OTC Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 80
TABLE NO. 23. : Global Self-test or OTC Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 80
TABLE NO. 24. : Global Central Laboratories Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 82
TABLE NO. 25. : Global Central Laboratories Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 82
TABLE NO. 26. : Global In Situ Hybridization Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 88
TABLE NO. 27. : Global In Situ Hybridization Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 88
TABLE NO. 28. : Global Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 90
TABLE NO. 29. : Global Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 90
TABLE NO. 30. : Global Chips and Microarrays Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 92
TABLE NO. 31. : Global Chips and Microarrays Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 92
TABLE NO. 32. : Global Mass Spectrometry Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 94
TABLE NO. 33. : Global Mass Spectrometry Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 94
TABLE NO. 34. : Global Others Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 96
TABLE NO. 35. : Global Others Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 96
TABLE NO. 36. : Global Molecular Diagnostics Market Revenue, By Region, 2018 – 2023 (USD Million) 101
TABLE NO. 37. : Global Molecular Diagnostics Market Revenue, By Region, 2024 – 2032 (USD Million) 101
TABLE NO. 38. : Global Molecular Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 102
TABLE NO. 39. : Global Molecular Diagnostics Market Revenue, By Product, 2024 – 2032 (USD Million) 102
TABLE NO. 40. : Global Molecular Diagnostics Market Revenue, By Application, 2018 – 2023 (USD Million) 103
TABLE NO. 41. : Global Molecular Diagnostics Market Revenue, By Application, 2024 – 2032 (USD Million) 103
TABLE NO. 42. : Global Molecular Diagnostics Market Revenue, By Test Location, 2018 – 2023 (USD Million) 104
TABLE NO. 43. : Global Molecular Diagnostics Market Revenue, By Test Location, 2024 – 2032 (USD Million) 104
TABLE NO. 44. : Global Molecular Diagnostics Market Revenue, By Technology, 2018 – 2023 (USD Million) 105
TABLE NO. 45. : Global Molecular Diagnostics Market Revenue, By Technology, 2024 – 2032 (USD Million) 105
TABLE NO. 46. : North America Molecular Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 107
TABLE NO. 47. : North America Molecular Diagnostics Market Revenue, By Country, 2024 – 2032 (USD Million) 107
TABLE NO. 48. : North America Molecular Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 108
TABLE NO. 49. : North America Molecular Diagnostics Market Revenue, By Product, 2024 – 2032 (USD Million) 108
TABLE NO. 50. : North America Molecular Diagnostics Market Revenue, By Application, 2018 – 2023 (USD Million) 109
TABLE NO. 51. : North America Molecular Diagnostics Market Revenue, By Application, 2024 – 2032 (USD Million) 109
TABLE NO. 52. : North America Molecular Diagnostics Market Revenue, By Test Location, 2018 – 2023 (USD Million) 110
TABLE NO. 53. : North America Molecular Diagnostics Market Revenue, By Test Location, 2024 – 2032 (USD Million) 110
TABLE NO. 54. : North America Molecular Diagnostics Market Revenue, By Technology, 2018 – 2023 (USD Million) 111
TABLE NO. 55. : North America Molecular Diagnostics Market Revenue, By Technology, 2024 – 2032 (USD Million) 111
TABLE NO. 56. : Europe Molecular Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 114
TABLE NO. 57. : Europe Molecular Diagnostics Market Revenue, By Country, 2024 – 2032 (USD Million) 114
TABLE NO. 58. : Europe Molecular Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 115
TABLE NO. 59. : Europe Molecular Diagnostics Market Revenue, By Product, 2024 – 2032 (USD Million) 115
TABLE NO. 60. : Europe Molecular Diagnostics Market Revenue, By Application, 2018 – 2023 (USD Million) 116
TABLE NO. 61. : Europe Molecular Diagnostics Market Revenue, By Application, 2024 – 2032 (USD Million) 116
TABLE NO. 62. : Europe Molecular Diagnostics Market Revenue, By Test Location, 2018 – 2023 (USD Million) 117
TABLE NO. 63. : Europe Molecular Diagnostics Market Revenue, By Test Location, 2024 – 2032 (USD Million) 117
TABLE NO. 64. : Europe Molecular Diagnostics Market Revenue, By Technology, 2018 – 2023 (USD Million) 118
TABLE NO. 65. : Europe Molecular Diagnostics Market Revenue, By Technology, 2024 – 2032 (USD Million) 118
TABLE NO. 66. : Asia Pacific Molecular Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 121
TABLE NO. 67. : Asia Pacific Molecular Diagnostics Market Revenue, By Country, 2024 – 2032 (USD Million) 121
TABLE NO. 68. : Asia Pacific Molecular Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 122
TABLE NO. 69. : Asia Pacific Molecular Diagnostics Market Revenue, By Product, 2024 – 2032 (USD Million) 122
TABLE NO. 70. : Asia Pacific Molecular Diagnostics Market Revenue, By Application, 2018 – 2023 (USD Million) 123
TABLE NO. 71. : Asia Pacific Molecular Diagnostics Market Revenue, By Application, 2024 – 2032 (USD Million) 123
TABLE NO. 72. : Asia Pacific Molecular Diagnostics Market Revenue, By Test Location, 2018 – 2023 (USD Million) 124
TABLE NO. 73. : Asia Pacific Molecular Diagnostics Market Revenue, By Test Location, 2024 – 2032 (USD Million) 124
TABLE NO. 74. : Asia Pacific Molecular Diagnostics Market Revenue, By Technology, 2018 – 2023 (USD Million) 125
TABLE NO. 75. : Asia Pacific Molecular Diagnostics Market Revenue, By Technology, 2024 – 2032 (USD Million) 125
TABLE NO. 76. : Latin America Molecular Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 128
TABLE NO. 77. : Latin America Molecular Diagnostics Market Revenue, By Country, 2024 – 2032 (USD Million) 128
TABLE NO. 78. : Latin America Molecular Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 129
TABLE NO. 79. : Latin America Molecular Diagnostics Market Revenue, By Product, 2024 – 2032 (USD Million) 129
TABLE NO. 80. : Latin America Molecular Diagnostics Market Revenue, By Application, 2018 – 2023 (USD Million) 130
TABLE NO. 81. : Latin America Molecular Diagnostics Market Revenue, By Application, 2024 – 2032 (USD Million) 130
TABLE NO. 82. : Latin America Molecular Diagnostics Market Revenue, By Test Location, 2018 – 2023 (USD Million) 131
TABLE NO. 83. : Latin America Molecular Diagnostics Market Revenue, By Test Location, 2024 – 2032 (USD Million) 131
TABLE NO. 84. : Latin America Molecular Diagnostics Market Revenue, By Technology, 2018 – 2023 (USD Million) 132
TABLE NO. 85. : Latin America Molecular Diagnostics Market Revenue, By Technology, 2024 – 2032 (USD Million) 132
TABLE NO. 86. : Middle East Molecular Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 135
TABLE NO. 87. : Middle East Molecular Diagnostics Market Revenue, By Country, 2024 – 2032 (USD Million) 135
TABLE NO. 88. : Middle East Molecular Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 136
TABLE NO. 89. : Middle East Molecular Diagnostics Market Revenue, By Product, 2024 – 2032 (USD Million) 136
TABLE NO. 90. : Middle East Molecular Diagnostics Market Revenue, By Application, 2018 – 2023 (USD Million) 137
TABLE NO. 91. : Middle East Molecular Diagnostics Market Revenue, By Application, 2024 – 2032 (USD Million) 137
TABLE NO. 92. : Middle East Molecular Diagnostics Market Revenue, By Test Location, 2018 – 2023 (USD Million) 138
TABLE NO. 93. : Middle East Molecular Diagnostics Market Revenue, By Test Location, 2024 – 2032 (USD Million) 138
TABLE NO. 94. : Middle East Molecular Diagnostics Market Revenue, By Technology, 2018 – 2023 (USD Million) 139
TABLE NO. 95. : Middle East Molecular Diagnostics Market Revenue, By Technology, 2024 – 2032 (USD Million) 139
TABLE NO. 96. : Africa Molecular Diagnostics Market Revenue, By Country, 2018 – 2023 (USD Million) 142
TABLE NO. 97. : Africa Molecular Diagnostics Market Revenue, By Country, 2024 – 2032 (USD Million) 142
TABLE NO. 98. : Africa Molecular Diagnostics Market Revenue, By Product, 2018 – 2023 (USD Million) 143
TABLE NO. 99. : Africa Molecular Diagnostics Market Revenue, By Product, 2024 – 2032 (USD Million) 143
TABLE NO. 100. : Africa Molecular Diagnostics Market Revenue, By Application, 2018 – 2023 (USD Million) 144
TABLE NO. 101. : Africa Molecular Diagnostics Market Revenue, By Application, 2024 – 2032 (USD Million) 144
TABLE NO. 102. : Africa Molecular Diagnostics Market Revenue, By Test Location, 2018 – 2023 (USD Million) 145
TABLE NO. 103. : Africa Molecular Diagnostics Market Revenue, By Test Location, 2024 – 2032 (USD Million) 145
TABLE NO. 104. : Africa Molecular Diagnostics Market Revenue, By Technology, 2018 – 2023 (USD Million) 146
TABLE NO. 105. : Africa Molecular Diagnostics Market Revenue, By Technology, 2024 – 2032 (USD Million) 146

Request Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices

Providing the strategic compass for industry titans.

Frequently Asked Question:

What is the projected market size of the molecular diagnostics market in 2023 and 2032?

The molecular diagnostics market is projected to reach USD 15,293.47 million in 2023 and is expected to grow to USD 23,221.61 million by 2032.

What is the compound annual growth rate (CAGR) for the molecular diagnostics market?

The molecular diagnostics market is anticipated to grow at a compound annual growth rate (CAGR) of 4.75% from 2024 to 2032.

What are the key drivers of growth in the molecular diagnostics market?

Key drivers include the increasing adoption of personalized medicine, advancements in testing technologies like next-generation sequencing, and a growing need for rapid and accurate diagnostic testing.

Which regions are leading in the molecular diagnostics market?

North America currently dominates the molecular diagnostics market due to its well-established healthcare systems, followed by Europe and the Asia-Pacific region, which is expected to experience the fastest growth.

What types of technologies are used in molecular diagnostics?

The molecular diagnostics market encompasses various technologies, including Polymerase Chain Reaction (PCR), sequencing, and microarrays, which are essential for disease detection, monitoring, and treatment optimization.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports By Keyword

Turbomolecular Pumps Market

Turbomolecular Pumps Market size was valued at USD 2690 million in 2024 and is anticipated to reach USD 5204.6 million by 2032, at a CAGR of 8.6% during the forecast period.

Molecular Weight Markers Market

The Molecular Weight Markers market size was valued at USD 387.3 million in 2018, grew to USD 841.4 million in 2024, and is anticipated to reach USD 2,259.8 million by 2032, at a CAGR of 13.19% during the forecast period.

Molecular Modelling Market

Molecular Modelling Market size was valued at USD 7,070 million in 2024 and is anticipated to reach USD 19334 million by 2032, at a CAGR of 13.4% during the forecast period (2024-2032).

Molecular Beam Epitaxy Market

Molecular Beam Epitaxy Market size was valued at USD 94.8 million in 2024 and is anticipated to reach USD 178 million by 2032, at a CAGR of 8.2% during the forecast period (2024-2032).

At-Home Molecular Testing Market

The At-Home Molecular Testing Market is projected to grow from USD 10,212 million in 2024 to USD 16,153.94 million by 2032, at a compound annual growth rate (CAGR) of 5.9%.

Next Generation Molecular Assay Market

The Next Generation Molecular Assay Market size was valued at USD 5,030 million in 2024 and is anticipated to reach USD 7,408.98 million by 2032, at a CAGR of 4.96% during the forecast period (2024-2032).

Molecular Glues Market

The Molecular Glues Market is projected to grow from USD 58,021.34 million in 2023 to USD 95,557.03 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.70%.

Molecular Quality Controls Market

The Molecular Quality Controls Market is projected to grow from USD 218.5 million in 2024 to USD 568.64 million by 2032, registering a robust CAGR of 12.7% during the forecast period.

Point of Care Molecular Diagnostics Market

The Point of Care (POC) Molecular Diagnostics Market is projected to grow from USD 4405 million in 2024 to USD 9104.55 million by 2032, at a compound annual growth rate (CAGR) of 9.5%.

Purchase Options

Single User

$4999

Multi User

$6999

Enterprise

$12999

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

KIERAN JAMESON, Australia

+61 4192 46279

Report delivery within 24 to 48 hours

What people say?

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

Trusted By

Request Sample